Navigation Links
Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet
Date:3/20/2008

HAMBURG, Germany and OXFORD, England, March 20 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) is going to broadcast its annual analyst and press conference in Frankfurt on the occasion of the publication of its fiscal year 2007 results live on the internet. The presentation will be held in English.

Date: Friday, March 28, 2008

Time: 10.30 am CET (09.30 am GMT/05.30 am EDT)

To join the audio webcast and to access the presentation slides you will find a link on our home page http://www.evotec.com shortly before the event.
For those who prefer to listen to the presentation via phone, please dial:

From Europe: +49-69-5007-1308 (Germany)

+44-207-806-1956 (UK)

From the US: +1-718-354-1389

Access Code: 4484272

The on-demand version of the webcast will be available on our website: http://www.evotec.com - Investors - Webcasts.

Contact:

Evotec AG

Anne Hennecke

SVP, Investor Relations & Corporate Communications

Phone: +49-40-56081-286

Fax: +49-40-56081-333

E-Mail: anne.hennecke@evotec.com


'/>"/>
SOURCE Evotec AG
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Evotec to Present at the Cowen and Company 28th Annual Health Care Conference in Boston
2. Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery
3. Evotec Expands Collaboration With InterMune
4. Evotec Starts Phase II in Smoking Cessation with EVT 302
5. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
6. Evotec to Present at the BIO CEO & Investor Conference 2008 in New York
7. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
8. Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board
9. Evotec Reports Third Quarter 2007 Results
10. Evotec AG: R&D Update on 16 October 2007 Live on the Internet
11. Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2